What is Dr. Reddy's Laboratories Limited's Shariah compliance score?

Dr. Reddy's Laboratories Limited (RDY) has a Shariah compliance score of 75/100 (Grade: B+, Good) based on AAOIFI screening standards. Scores above 70 typically indicate strong compliance. The score factors in business activity screening and financial ratio analysis including debt levels, interest-bearing deposits, and prohibited income percentages. View the full breakdown at HalalScreener.app.

Does Dr. Reddy's Laboratories Limited pass AAOIFI screening?

Dr. Reddy's Laboratories Limited (RDY) passes AAOIFI Shariah screening. AAOIFI requires: (1) no primary involvement in prohibited activities like alcohol, gambling, or conventional banking, (2) debt-to-market-cap below 30% (RDY: 7.4%), (3) interest-bearing deposits below 30% (RDY: 8.4%), and (4) prohibited income below 5% (RDY: 2.3%). HalalScreener provides free AAOIFI screening for 10,000+ stocks at halalscreener.app.

How much purification is needed for Dr. Reddy's Laboratories Limited stock?

Dr. Reddy's Laboratories Limited (RDY) has a non-permissible income ratio of 2.34%. Muslim investors should purify this percentage of any dividends received and capital gains realized from RDY shares by donating it to charity. HalalScreener's purification calculator at halalscreener.app/en/purification automates this calculation using the latest financial data.

Where can I screen Dr. Reddy's Laboratories Limited for Shariah compliance for free?

HalalScreener (halalscreener.app) offers free Shariah compliance screening for Dr. Reddy's Laboratories Limited (RDY) and 10,000+ other US-listed stocks, ETFs, and 100+ cryptocurrencies. The screening uses AAOIFI Standard No. 21 and shows all financial ratios transparently. No credit card or signup required for basic screening. HalalScreener also includes an AI Islamic Scholar for follow-up questions about RDY's compliance across different madhabs (Hanafi, Shafi'i, Maliki, Hanbali, Ja'fari).

RDY: Is Dr. Reddy's Laboratories Limited Halal?

Dr. Reddy's Laboratories Limited

NYSEHealthcareIN

$12.84

-0.62%

Market Cap: 10.7B

Compliance Status

Halal

Screened on Jul 15, 2026 · AAOIFI Standard 21

B+

Good

75Score

Is Dr. Reddy's Laboratories Limited (RDY) halal? Halal. Based on AAOIFI screening, Dr. Reddy's Laboratories Limited passes both qualitative (business activity) and quantitative (financial ratio) screens with a compliance score of 75/100 (Grade: B+).

AvoidBorderlineClean

Business activity

What the company sells is permissible.

Passed

Company debt

Well clear of the limit

How much the company borrows, compared to its total value. AAOIFI allows up to 30%.

7.4% of 30.0% limit

What this means for you

You can own RDY

It passes both the business activity and financial ratio screens under AAOIFI Standard 21.

Purify 2.3% of your income from RDY

That is about $2.30 of every $100 you earn from it. Donate this share to charity.

Calculate my exact amount

About Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited, alongside its associated companies, functions as a holistic pharmaceutical entity with a global footprint. Its business operations are divided into several key divisions. The Global Generics segment is responsible for the manufacturing and sale of both prescription and over-the-counter finished pharmaceutical products. These offerings are available either under a proprietary brand or as generic formulations that are therapeutically identical to their branded equivalents. This segment also includes the company's biologics ventures. The Pharmaceutical Services and Active Ingredients (PSAI) division focuses on producing and distributing active pharmaceutical ingredients (APIs) and chemical intermediates, which serve as crucial building blocks for final drug products. Additionally, PSAI provides contract research services and produces custom-specified APIs and steroids for clients. The Proprietary Products segment is dedicated to the research and advancement of unique pharmaceutical formulations. The Others segment is actively involved in developing treatments, primarily for oncology (cancer) and inflammatory conditions. Dr. Reddy's addresses a broad spectrum of therapeutic areas, including gastrointestinal issues, cardiovascular health, diabetes, dermatological concerns, cancer, respiratory diseases, oral health, urological disorders, and nephrological conditions. The company has also established a partnership with Curis, Inc., centered on the discovery, development, and commercialization of small molecule antagonists designed for immuno-oncology and precision oncology targets. Founded in 1984, Dr. Reddy's Laboratories Limited maintains its principal office in Hyderabad, India.

Sector: Healthcare · Industry: Drug Manufacturers - Specialty & Generic

Shariah Compliance Status

AAOIFI Standard 21Updated Jul 15, 2026

Compliance History

Halalnow
since Jun 2026
Not Halal
until the change above

Tracked since Jun 2026. Updates automatically on each re-screen.

Fiscal: FY 2026Data source: FMP-ADR

More Healthcare Stocks

JNJ

Johnson & Johnson

UNH

UnitedHealth Group Incorporated

B+

ABBV

AbbVie Inc.

PFE

Pfizer Inc.

LLY

Eli Lilly and Company

A+

MRK

Merck & Co., Inc.

B+

Free · No credit card required

Track RDY and 10,000+ stocks with AI insights

Create your free account to unlock AI-powered compliance analysis, track your portfolio, calculate purification, and get unlimited AAOIFI screening.

Get Started Free Browse Screener

10,000+ assets AAOIFI standards Free watchlist

Frequently Asked Questions

Is Dr. Reddy's Laboratories Limited (RDY) halal to invest in?

Based on AAOIFI Standard 21 screening, Dr. Reddy's Laboratories Limited (RDY) is rated Halal with a compliance grade of B+ (Good). It passes both the business activity screen (no primary involvement in prohibited sectors) and the quantitative financial ratio screen (debt, interest deposits, and prohibited income all below AAOIFI thresholds).

Why did Dr. Reddy's Laboratories Limited get a B+ compliance rating?

Dr. Reddy's Laboratories Limited (RDY) received a grade of B+ (Good) based on three AAOIFI Standard 21 financial ratios: debt-to-market-cap of 7.4% (limit 30%); interest-bearing deposits of 8.4% (limit 30%); prohibited income of 2.34% (limit 5%). The grade reflects the margin of safety across all three ratios relative to their thresholds.

What could change Dr. Reddy's Laboratories Limited's Shariah verdict?

Dr. Reddy's Laboratories Limited's verdict is re-evaluated at each annual re-screen. Three events could change it: (1) the debt-to-market-cap ratio crossing 30%, typically from new debt issuance or a major drop in share price; (2) interest-bearing deposits exceeding 30% of market cap; or (3) prohibited revenue (alcohol, gambling, conventional finance, etc.) exceeding 5% of total revenue. Verdict flips are tracked in the compliance history section above.

How often is Dr. Reddy's Laboratories Limited re-screened for Shariah compliance?

Dr. Reddy's Laboratories Limited (RDY) is re-screened annually using the most recent full-year financial data from SEC filings. HalalScreener also triggers an on-demand re-screen whenever the stored data is more than 7 days old, ensuring the ratios reflect the latest available financial statements. Last screened: Jul 15, 2026.

Screened according to AAOIFI Standard No. 21 · For informational purposes only. Consult a qualified Islamic finance advisor before investing.

Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.